Skip to main content
Clinical Trials/NCT03184974
NCT03184974CompletedNot Applicable

Individualized Open Lung PEEP in Thoracic Surgery: A Prospective Multicenter Observational Study in 17 Spanish Hospitals

Fundación para la Investigación del Hospital Clínico de Valencia0 sites690 target enrollmentStarted: October 1, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
690
Primary Endpoint
Postoperative pulmonary complications

Study Overview

Brief Summary

During thoracic surgical procedures, while ventilating with a protective tidal volume, an open lung approach consisting of a recruitment maneuver followed by an individualized positive end-expiratory pressure (PEEP) titrated to best respiratory system compliance (Open-lung PEEP, OL-PEEP) would decrease driving pressure. To test this hypothesis, we performed a multicenter observational study in 17 Spanish teaching hospitals of patients undergoing one lung ventilation (OLV). In addition, we analyzed the association between the driving pressure and the prevalence of postoperative pulmonary complications (PPCs), and finally the association between the individualized PEEP and relevant patient preoperative or intraoperative variables.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients undergoing one lung ventilation

Exclusion Criteria

  • No exclusion criteria

Outcomes

Primary Outcomes

Postoperative pulmonary complications

Time Frame: Postoperative. One week

Atelectasis, acute respiratory failure, ARDS, pneumonia, reintubation, empyema, bronchospasm, pneumothorax, pneumonitis, bronchopleural fistula

Secondary Outcomes

  • Descriptive analysis of the open lung PEEP(intraoperative)

Investigators

Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Carlos Ferrando

Principal investigador

Fundación para la Investigación del Hospital Clínico de Valencia

Similar Trials